Latest news
Nuvation Bio Inc (NUVB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 23:05:06 GMTNUVB Stock Is Soaring Today — Why RBC Sees $3B Opportunity In Nuvation Bio's Brain Cancer Drug - StocktwitsStocktwits · Fri, 07 Aug 2026 15:55:52 GMTB. Riley Adjusts Price Target on Nuvation Bio to $15 From $12, Maintains Buy Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 14:19:35 GMTWhy Nuvation Bio (NUVB) Is Down 8.8% After Surging Q2 2026 Revenue and IBTROZI Data Tease - simplywall.stsimplywall.st · Fri, 07 Aug 2026 12:39:51 GMTNUVB SWOT Analysis: Revenue Surge Amidst Ongoing Losses Revealed in 10-Q Filing - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:26:46 GMTBronstein, Gewirtz & Grossman, LLC Encourages Nuvation Bio Inc - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 04:46:04 GMTNuvation Bio Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 17:37:23 GMTNuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:50:12 GMT